Yüklüyor......
Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)
Renal cell carcinoma (RCC) is the most common renal cancer, and has a poor prognosis in individuals with metastases (mRCC). In this report, we describe a 48-year-old woman with unresectable multiple liver metastases and a colonic metastasis of RCC who was treated with sunitinib in combination with h...
Kaydedildi:
| Yayımlandı: | Urol Case Rep |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385577/ https://ncbi.nlm.nih.gov/pubmed/28409120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2016.11.024 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|